blogAdmin

Addressing Misinformation About Down Syndrome

By Stephanie Meredith, MA, DrPH and Viviane Polarson, MS, CGC A recent viral video posted by a popular YouTuber with more than five million followers has brought renewed attention to a topic that genetic counselors, medical professionals, and Down syndrome advocacy organizations care deeply about: the quality of information available to pregnant patients at the …

Addressing Misinformation About Down Syndrome Read More »

Genetic Support Foundation Awarded Funding to Identify Patient-Centered Achondroplasia Research Priorities

We are pleased to announce that the Genetic Support Foundation (GSF) has been approved for a funding award through the Eugene Washington PCORI Engagement Award Program, an initiative of the Patient-Centered Outcomes Research Institute (PCORI). The funds will support a new project titled “Convening to Identify Patient-Centered CER Priorities of Individuals with Achondroplasia and Families.”  …

Genetic Support Foundation Awarded Funding to Identify Patient-Centered Achondroplasia Research Priorities Read More »

HRSA Grant Progress Update – Year 2 Highlights

We’re excited to share the remarkable progress made during year two of our multi-year HRSA Healthy Tomorrows Partnership for Children Program (HTPCP) grant, which funds our continued efforts to expand access to genetic healthcare across the Pacific Northwest. Expanded Patient Care and Community Impact This past year marked significant growth in our ability to serve …

HRSA Grant Progress Update – Year 2 Highlights Read More »

Who Defines “Health” and What Purpose Does Its Definition Serve?

By Devin Shuman, CGC (she/her) and Andrea Schelhaas, CGC (she/her) *Of note, we purposefully use capital D in Disabled and capital A in Autistic in this text as individuals who embrace disability as a core part of our identities and who are part of the larger Disability community advocating for disability rights and equality.  Today, …

Who Defines “Health” and What Purpose Does Its Definition Serve? Read More »

Pharma’s Role in Practice Guideline Development: Achondroplasia as a Case Study

By Andrea Schelhaas, Stephanie Meredith and Katie Stoll In November 2021 under the Accelerated Approval Program, the U.S. Food and Drug Administration announced approval of Voxzogo (vosoritide), a drug developed by BioMarin for the purpose of increasing linear growth in children with achondroplasia with open growth plates (individuals who are actively growing). Achondroplasia is the …

Pharma’s Role in Practice Guideline Development: Achondroplasia as a Case Study Read More »